Advisory Services Network’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$711K Sell
11,112
-5,382
-33% -$354K 0.01% 1206
2026
Q1
$1.17M Sell
16,494
-289
-2% -$22.8K 0.02% 855
2025
Q4
$1.38M Sell
16,783
-4,822
-22% -$376K 0.02% 757
2025
Q3
$1.62M Buy
21,605
+575
+3% +$42.9K 0.02% 664
2025
Q2
$1.5M Sell
21,030
-411
-2% -$28.6K 0.02% 661
2025
Q1
$1.73M Sell
21,441
-688
-3% -$59.1K 0.03% 549
2024
Q4
$1.73M Buy
22,129
+769
+4% +$65.4K 0.03% 541
2024
Q3
$1.66M Hold
21,360
0.03% 527
2024
Q2
$1.66M Buy
21,360
+5,711
+36% +$466K 0.03% 527
2024
Q1
$1.42M Buy
15,649
+3,100
+25% +$258K 0.03% 561
2023
Q4
$970K Buy
12,549
+1,652
+15% +$116K 0.02% 645
2023
Q3
$741K Buy
10,897
+1,051
+11% +$76.5K 0.02% 750
2023
Q2
$800K Sell
9,846
-968
-9% -$77.2K 0.02% 710
2023
Q1
$887K Buy
+10,814
New +$772K 0.02% 655

Other funds holding GEHC

Advisory Services Network's GEHC Position: Q2 2026 in Review

Advisory Services Network reduced its GE HealthCare (GEHC) stake by 33% in Q2 2026, selling an estimated $354K and leaving 11,112 shares worth $711K. The position accounts for 0.01% of the portfolio, ranked #1206.

Advisory Services Network first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.73M in Q1 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Advisory Services Network held 11,112 shares of GE HealthCare worth $711K as of Q2 2026.
  • Advisory Services Network sold 5,382 GE HealthCare shares in Q2 2026, an estimated $354K.
  • GE HealthCare made up 0.01% of Advisory Services Network's portfolio in Q2 2026, its #1206 holding.
  • Advisory Services Network first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Advisory Services Network's GE HealthCare position peaked at $1.73M in Q1 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.